Advisory Services Network, LLC - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 161 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Advisory Services Network, LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2023$7,196
-19.3%
2000.0%0.00%–
Q4 2022$8,914
+791.4%
200
+1076.5%
0.00%–
Q2 2021$1,000–170.0%0.00%–
Q4 2020$0–170.0%0.00%–
Q3 2020$0–170.0%0.00%–
Q1 2020$0–170.0%0.00%–
Q4 2019$0–170.0%0.00%–
Q3 2019$0–170.0%0.00%–
Q2 2019$0–170.0%0.00%–
Q1 2019$0–17–0.00%–
 Download
Other shareholders

There were no reported owners of CELLDEX THERAPEUTICS INC NEW in Q1 2023.

NameSharesValueWeighting ↓
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders